- Home
- FGL vs PMN Comparison
FGL vs PMN Comparison
Compare FGL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- PMN
- Stock Information
- Founded
- FGL 2021
- PMN 2004
- Country
- FGL Malaysia
- PMN Canada
- Employees
- FGL N/A
- PMN N/A
- Industry
- FGL
- PMN Pharmaceuticals and Biotechnology
- Sector
- FGL
- PMN Health Care
- Exchange
- FGL NYSE
- PMN Nasdaq
- Market Cap
- FGL 27.4M
- PMN 29.8M
- IPO Year
- FGL 2024
- PMN N/A
- Fundamental
- Price
- FGL $1.50
- PMN $0.82
- Analyst Decision
- FGL
- PMN
- Analyst Count
- FGL 0
- PMN 0
- Target Price
- FGL N/A
- PMN N/A
- AVG Volume (30 Days)
- FGL 144.3K
- PMN 44.2K
- Earning Date
- FGL 12-17-2024
- PMN 03-31-2025
- Dividend Yield
- FGL N/A
- PMN N/A
- EPS Growth
- FGL 45.69
- PMN N/A
- EPS
- FGL 0.04
- PMN N/A
- Revenue
- FGL $23,268,519.00
- PMN N/A
- Revenue This Year
- FGL N/A
- PMN N/A
- Revenue Next Year
- FGL N/A
- PMN N/A
- P/E Ratio
- FGL $41.34
- PMN N/A
- Revenue Growth
- FGL 336.06
- PMN N/A
- 52 Week Low
- FGL $1.25
- PMN $0.81
- 52 Week High
- FGL $5.26
- PMN $2.61
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- PMN 36.19
- Support Level
- FGL N/A
- PMN $0.81
- Resistance Level
- FGL N/A
- PMN $0.94
- Average True Range (ATR)
- FGL 0.00
- PMN 0.07
- MACD
- FGL 0.00
- PMN -0.01
- Stochastic Oscillator
- FGL 0.00
- PMN 6.07
About FGL FOUNDER GROUP LTD
Founder Group Ltd acts as an end-to-end Engineering, Procurement, Construction, and Commissioning solutions provider for solar PV facilities in Malaysia. The segments of the company are large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects of the company are utility-scale solar PV power plants with installed generating capacity of 1 MWac or more, and C&I projects of the company are smaller-scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their consumption at factories, warehouses, and commercial stores. The company derives its revenue from Malaysia.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.